CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
85 hedge funds and large institutions have $203M invested in Concert Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $227M → $203M (-$24.5M)
Holders
85
Holding in Top 10
1
Calls
$1.12M
Puts
$224K
Top Buyers
| 1 | +$16M | |
| 2 | +$6.25M | |
| 3 | +$3.19M | |
| 4 |
BlackRock
New York
|
+$2.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.58M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$5.93M | |
| 3 | -$3.84M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.26M |
| 5 |
Morgan Stanley
New York
|
-$2.21M |